SV Health Investors

SV Health Investors

Xconomy

X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis

$30,000,000 Venture capital (Series A)
PE HUB

Ribometrix scores $30 mln Series A

FinSMEs , Xconomy

Ribometrix Raises $30M in Series A Funding

PE HUB

VC-backed Sutro Biopharma debuts IPO

MedCity News

For Endotronix, a digital health medtech startup, FDA has dual identities

FinSMEs , PE HUB

Endotronix Raises $45M in Series D Financing

Health Funding
£65,000,000 Venture capital (Series B)
FinSMEs

DNA Damage Response Company Artios Pharma Raises £65M in Series B

Funding Science
$30,000,000 Venture capital (Series C)
PE HUB

Evidation Health scores $30 mln Series C

Messaging
FinSMEs

Evidation Health Raises $30M in Series C Venture Capital Funding

Health Funding Cloud
$85,400,000 Venture capital (Series E)
PE HUB

Sutro Biopharma snags $85.4 mln Series E

Messaging
FinSMEs

Sutro Biopharma Raises $85.4M in Series E Funding Round

Funding Health
Undisclosed funding
FinSMEs

Bardy Diagnostics Raises Further Growth Capital from Existing Investors

Funding Health
$99,700,000 IPO
PE HUB

VC-backed Avrobio rolls out IPO

Stock markets Health
$60,000,000 Venture capital (Series B)
FinSMEs , Xconomy , MedCity News

Avrobio Raises $60M in Series B Financing

Health Funding
$7,500,000 Seed fund
PE HUB

Biotech company Ribometrix snags $7.5 mln seed

Xconomy

Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug

Health Funding
Xconomy

Celgene Narrows Its Relationship With Sutro, No Acquisition Coming

Health
$10,000,000 Venture capital
PE HUB

Evidation Health takes in $10 mln

Data leaks Funding
$45,500,000 Venture capital (Series D)
PE HUB

Arsanis nabs $45.5 mln Series D

Funding Data leaks Messaging
$9,300,000 Grant
GEN

Arsanis Licenses Adimab RSV Antibodies and Wins $9.3M from Bill & Melinda Gates Foundation Genetic Engineering & Biotech...